Drugs for the heart and hypertension

TWO PHARMACEUTICALS, used in the management of cardiovascular disease and hypertension, were recently launched on the local market by the drug's manufacturer, Sanofi-Synthelabo, a multinational company based in New York, USA.

The drugs are Plavix and Avapro. Plavix, an anti-platelet product which has been approved and used in the United States since 1998, according to the manufacturer, is clinically recognised for its high effective rate in the treatment of cardiovascular disease and its associated disorders of stroke and other ischemic condition (blocked blood vessel to the brain). It is also recognised for having minimal side effects, they say.

Avapro, which has been on the international market for more than four years, is used in the treatment of hypertension. It belongs to the new class of anti-hypertensive products called the angiotensin II receptor blockers. According to manufacturer's information, Avapro is a highly effective and tolerable medication and is also particularly regarded for its ability to lower the risk of cough.

Back to Profiles in Medicine